Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot pharmacokinetic study of high-dose ropivacaine with or without epinephrine for combined femoral and sciatic nerve block
NL-OMON21564Phase 4Not yet recruiting
- Sponsor
- Sint Maartenskliniek
- Start
- Sep 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of ropivacaine and epinephrine in pain, sponsored by Sint Maartenskliniek. Primary endpoints: Mean unbound and bound peak plasma concentration of ropivacaine, Mean time to peak plasma concentration of ropivacaine and 4 more. Planned start Sep 2009; status: not yet recruiting.
02
Drugs
ropivacaineepinephrine
03
Conditions
pain
Beyond the preview
Go deeper on NL-OMON21564.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON21564.